Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123539 · ClinicalTrials.gov registry record · NA
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Terminated
- Registry status
- NA
- Development phase
- 334
- Enrollment target
NCT00123539 is a NA study that was terminated before completion, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 334 participants.
The verdict
NCT00123539, a NA study, was terminated before completion, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- TERMINATED
- Registry status
- NA
- Development phase
- 334 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether perioperative estrogen replacement in postmenopausal women reduces the risk for neurologic injury after coronary artery bypass graft (CABG) surgery.
Interventions
- PROCEDURE Surgery
- DRUG Estrogen Replacement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2001-06 |
| Est. Completion | 2005-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00123539
The ClinicalTrials.gov registry entry for NCT00123539 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surgery is the first listed.
NCT00123539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00123539 about?
NCT00123539 is a clinical study titled "Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery". The purpose of this study is to test whether perioperative estrogen replacement in postmenopausal women reduces the risk for neurologic injury after coronary artery bypass graft (CABG) surgery.
What is the current status of trial NCT00123539?
This trial is currently terminated. It is a NA study. The enrollment target is 334 participants. The study started on 2001-06. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00123539?
The interventions under investigation include: Surgery (PROCEDURE), Estrogen Replacement Therapy (DRUG).
Who is sponsoring clinical trial NCT00123539?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.